a.k.a. Brands Holding Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $119.8M
- Price
- $10.90
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.77%
- Volume
- 473
About
a.k.a. Brands Holding Corp. operates a portfolio of online fashion brands in the United States, Australia, New Zealand, and internationally. The company offers dresses, tops, shoes, and accessories for customers between the ages of 15 and 25; dresses for special occasions for customers between 25 and 34; streetwear apparel, footwear, headwear, and accessories for male consumers between the ages of 18 and 35; and streetwear wardrobe staples through its online stores under the Princess Polly, Petal & Pup, Culture Kings, and mnml brands. It also operates physical retail stores. The company was founded in 2018 and is headquartered in San Francisco, California. a.k.a. Brands Holding Corp. is a subsidiary of New Excelerate, L.P.
Quick stats
Shares outstanding11.0M
Computed float778.1K
Float / shares7.1%
Key info
SectorConsumer Cyclical
IndustryApparel - Retail
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001865107
Websitehttp://www.aka-brands.com
AI Summary
AI-generated1/22
majorbullishother
Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
Aureka Biotechnologies closed a US$100 million Series B financing led by Granite Asia and a strategic investor, bringing total capital raised to nearly US$200 million.
Proceeds will primarily support research and large-scale training of next-generation biological foundation models, as well as upgrades to the Lab-in-the-Loop experimental feedback engine.
The company's AuraIDE model ranks among leaders in third-party evaluations for structure prediction and molecular design, supporting partnerships with global pharma firms that have generated tens of millions in revenue.